Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Critical roles of TRAIL in hepatic cell death and hepatic inflammation
Shi-Jun Zheng, … , Galit Tsabary, Youhai H. Chen
Shi-Jun Zheng, … , Galit Tsabary, Youhai H. Chen
Published January 1, 2004
Citation Information: J Clin Invest. 2004;113(1):58-64. https://doi.org/10.1172/JCI19255.
View: Text | PDF
Article Immunology

Critical roles of TRAIL in hepatic cell death and hepatic inflammation

  • Text
  • PDF
Abstract

The TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis of tumor cells but not most normal cells. Its role in hepatic cell death and hepatic diseases is not clear. In vitro studies suggest that murine hepatocytes are not sensitive to TRAIL-induced apoptosis, indicating that TRAIL may not mediate hepatic cell death. Using two experimental models of hepatitis, we found that hepatic cell death in vivo was dramatically reduced in TRAIL-deficient mice and mice treated with a blocking TRAIL receptor. Although both TRAIL and its death receptor 5 were constitutively expressed in the liver, TRAIL expression by immune cells alone was sufficient to restore the sensitivity of TRAIL-deficient mice to hepatitis. Thus, TRAIL plays a crucial role in hepatic cell death and hepatic inflammation.

Authors

Shi-Jun Zheng, Pu Wang, Galit Tsabary, Youhai H. Chen

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
TRAIL–/– mice are resistant to Con-A–induced hepatitis. Normal (TRAIL+/+...
TRAIL–/– mice are resistant to Con-A–induced hepatitis. Normal (TRAIL+/+) and TRAIL-deficient (TRAIL–/–) BALB/c mice, five per group, were injected once with Con-A (25 mg/kg of body weight) to induce hepatitis as described in Methods. Mice were sacrificed at different time points after the Con-A injection, and livers were harvested and tested as described in Methods. (a and b) Livers from TRAIL+/+ and TRAIL–/– mice, respectively, 24 hours after Con-A injection. (c and d) H&E staining of liver sections from TRAIL+/+ and TRAIL–/– mice, respectively, 24 hours after Con-A injection. The arrowhead indicates massive cell death in the TRAIL+/+ liver section. Original magnification, ×200. (e and f) TUNEL staining of liver sections from TRAIL+/+ and TRAIL–/– mice, respectively, 24 hours after Con-A injection. The arrowhead indicates an aggregate of apoptotic cells in the TRAIL+/+ liver section (apoptotic nuclei are shown in brown). Original magnification, ×200. (g) Numbers of apoptotic cells per square millimeter of liver sections of TRAIL+/+ and TRAIL–/– mice 24 hours after Con-A injection. The difference between the two groups is statistically significant (P < 0.0001). (h) Caspase-3 activity in the liver cytosolic protein extract at different time points after Con-A injection. The difference between the two groups is statistically significant (P < 0.01). Results shown are from one representative experiment of three.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts